Employer Info Session: SOPHiA GENETICS

At SOPHiA GENETICS, we are bringing the power of data and artificial intelligence to healthcare. Our AI tech platform analyzes genomic, radiomic, clinical, biological, and digital pathology data – to generate actionable insights for patients with cancer or rare diseases.

This event will feature two representatives from the company:

Kellen Sanger
Vice-President, Head of Strategy, SOPHiA Genetics

Today, over 1,051 healthcare institutions in 77 countries use our platform for genomic analytics, making us the #1 bioinformatics company in the world. Users include 15 of the top 20 global cancer centers (e.g., MD Anderson, MSK, Mayo Clinic, Dana Farber) and Vanderbilt Medical Center. To date, our platform has analyzed over 2.6 million patients globally, and over 500,000 patients this year alone.

The company is publicly traded (NASDAQ: SOPH) with offices in Boston and Geneva. Of our 400 employees, ~120 employees hold PhDs in molecular biology, bioinformatics and computational genomics, clinical and human genetics, biostatistics, statistical genetics, and ML/AI.